Paradigm Asset Management Co. LLC Sells 300 Shares of UnitedHealth Group Incorporated $UNH

Paradigm Asset Management Co. LLC cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 3.2% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 9,080 shares of the healthcare conglomerate’s stock after selling 300 shares during the quarter. UnitedHealth Group accounts for approximately 0.7% of Paradigm Asset Management Co. LLC’s investment portfolio, making the stock its 23rd largest position. Paradigm Asset Management Co. LLC’s holdings in UnitedHealth Group were worth $2,833,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. HHM Wealth Advisors LLC lifted its holdings in shares of UnitedHealth Group by 0.9% in the 1st quarter. HHM Wealth Advisors LLC now owns 2,947 shares of the healthcare conglomerate’s stock valued at $1,544,000 after acquiring an additional 26 shares during the last quarter. Brogan Financial Inc. raised its position in UnitedHealth Group by 3.4% during the first quarter. Brogan Financial Inc. now owns 819 shares of the healthcare conglomerate’s stock valued at $429,000 after purchasing an additional 27 shares during the period. West Wealth Group LLC boosted its holdings in shares of UnitedHealth Group by 3.2% in the 1st quarter. West Wealth Group LLC now owns 882 shares of the healthcare conglomerate’s stock worth $462,000 after purchasing an additional 27 shares during the period. Hemington Wealth Management raised its holdings in UnitedHealth Group by 2.5% during the 1st quarter. Hemington Wealth Management now owns 1,154 shares of the healthcare conglomerate’s stock valued at $604,000 after buying an additional 28 shares during the period. Finally, Tlwm boosted its stake in UnitedHealth Group by 1.0% during the first quarter. Tlwm now owns 2,736 shares of the healthcare conglomerate’s stock worth $1,433,000 after buying an additional 28 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $324.29 on Friday. The company’s 50 day moving average is $345.84 and its 200 day moving average is $323.37. The company has a market cap of $293.75 billion, a PE ratio of 16.93, a price-to-earnings-growth ratio of 2.28 and a beta of 0.47. The company has a current ratio of 0.82, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, topping the consensus estimate of $2.87 by $0.05. The business had revenue of $113.16 billion for the quarter, compared to analyst estimates of $113.19 billion. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The business’s quarterly revenue was up 12.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $7.15 EPS. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 16th. Investors of record on Monday, December 8th will be given a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.7%. The ex-dividend date is Monday, December 8th. UnitedHealth Group’s payout ratio is presently 46.14%.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on UNH shares. Piper Sandler dropped their price target on shares of UnitedHealth Group from $423.00 to $417.00 and set an “overweight” rating for the company in a research note on Tuesday, October 28th. KeyCorp boosted their price objective on shares of UnitedHealth Group from $350.00 to $400.00 and gave the company an “overweight” rating in a research report on Wednesday, October 8th. The Goldman Sachs Group assumed coverage on shares of UnitedHealth Group in a research note on Tuesday, October 14th. They set a “buy” rating and a $406.00 price target for the company. UBS Group raised their price objective on UnitedHealth Group from $378.00 to $430.00 and gave the stock a “buy” rating in a report on Wednesday, October 29th. Finally, Deutsche Bank Aktiengesellschaft downgraded UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 price objective on the stock. in a research report on Wednesday, October 29th. Eighteen analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $397.12.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.